How to CREATE Generic Pharma Competition

How to CREATE Generic Pharma Competition

By harnessing the business incentives of generic drug firms to limit the anticompetitive power of branded pharma­ceutical patent holders, the CREATES Act represents a straight-forward solution to a market failure created by exploitation of legal loopholes in drug industry regulation. It is a remedy that should be strongly supported by the White House and enacted by the new Congress.

K-Cups, Innovation and Interoperability

K-Cups, Innovation and Interoperability

Even before the landmark United States v. Microsoft Corp. antitrust case, competition law was a bit schizophrenic when it came to the question of interoperability. Monopolists have no general duty to make their products work with those of competitors, but what about the situation where a dominant firm deliberately re-designs products to render them incompatible with others? That […]

No Dodgers, No Merger

No Dodgers, No Merger

The anticompetitive effects of vertical integration by cable systems have now reached crisis proportions with the ongoing refusal — already more than five months old and with no end in sight — of Time Warner to license Los Angeles Dodgers baseball games for cable or satellite distribution, or local broadcast, on any network other than its own SportsNet LA programming channel.